No abstract available
MeSH terms
-
Administration, Inhalation
-
Adrenergic beta-Agonists / adverse effects*
-
Adrenergic beta-Agonists / therapeutic use
-
Advisory Committees*
-
Asthma / drug therapy
-
Bronchodilator Agents / adverse effects
-
Bronchodilator Agents / therapeutic use
-
Delayed-Action Preparations
-
Drug Approval
-
Drug Labeling
-
Humans
-
Risk Assessment
-
United States
-
United States Food and Drug Administration*
Substances
-
Adrenergic beta-Agonists
-
Bronchodilator Agents
-
Delayed-Action Preparations